What is your approach for managing nonresponders or partial responders to ritlecitinib in patients with alopecia areata?

Featuring E. James Song, MD, FAAD |

Co-Chief Medical Officer and Director of Clinical Research, Frontier Dermatology

Mill Creek, WA